sulfabenzamide   Click here for help

GtoPdb Ligand ID: 12632

Approved drug PDB Ligand
sulfabenzamide is an approved drug (FDA (1945))
Compound class: Synthetic organic
Comment: Sulfabenzamide is a sulfonamide antibacterial compound. It inhibits the bacterial dihydropteroate synthase pathway which generates the folic acid that is essential for bacterial growth.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 97.64
Molecular weight 276.31
XLogP 0.08
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=CC=C(C=C1)C(=O)NS(=O)(=O)C2=CC=C(C=C2)N
Isomeric SMILES C1=CC=C(C=C1)C(=O)NS(=O)(=O)C2=CC=C(C=C2)N
InChI InChI=1S/C13H12N2O3S/c14-11-6-8-12(9-7-11)19(17,18)15-13(16)10-4-2-1-3-5-10/h1-9H,14H2,(H,15,16)
InChI Key PBCZLFBEBARBBI-UHFFFAOYSA-N
References
1. Achari A, Somers DO, Champness JN, Bryant PK, Rosemond J, Stammers DK. (1997)
Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase.
Nat Struct Biol, 4 (6): 490-7. [PMID:9187658]
2. Bermingham A, Derrick JP. (2002)
The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery.
Bioessays, 24 (7): 637-48. [PMID:12111724]
3. Ovung A, Bhattacharyya J. (2021)
Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions.
Biophys Rev, 13 (2): 259-272. [PMID:33936318]